Ns-018
Title | Journal |
---|---|
A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis. | Leukemia 20170201 |
Effect of NS-018, a selective JAK2V617F inhibitor, in a murine model of myelofibrosis. | Blood cancer journal 20140101 |
Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms. | Blood cancer journal 20110701 |